SGLT2 inhibition causes vasodilation by preventing oxidative stress-induced inhibition of eNOS, improving NO bioavailability, and reducing endothelial dysfunction through sirtuin 1 activation (Figure 6) [393]. The gene discussed is NOS3; the disease is endothelial dysfunction.